Drug Trial Radar · NCT03684044
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza
Last checked: Nov 20, 2026Latest source record: Jan 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
363
Actual
Start
Jan 8, 2019
Primary completion
Mar 16, 2020
Study completion Mar 16, 2020
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Sep 25, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy, safety, and pharmacokinetics of baloxavir marboxil in combination with a standard-of-care (SOC) neuraminidase inhibitor (NAI) (i.e., oseltamivir, zanamivir, or peramivir) compared with a matching placebo in combination with a SOC NAI in hospitalized patients with influenza.
Conditions
- Influenza
Interventions
Baloxavir MarboxilDrug
Baloxavir marboxil will be administered as a weight-based dose on Days 1 and 4. A third dose will be given on Day 7 for participants who have not improved according to protocol defined criteria on Day 5.
PlaceboOther
Participants will receive matching placebo on Days 1, 4 and 7.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Clinical ImprovementTime frame: Up to Day 35
Locations
170 sites in 28 countries. Site status is shown where the registry gives one.
Torrance Memorial Medical Center
Torrance, California
Denver Health Medical Center
Denver, Colorado
Atlanta Institute For Medical Research, Inc; DeKalb Medical Pharmacy
Decatur, Georgia
University of Chicago; Oncology Dept
Chicago, Illinois
NorthShore University HealthSystem
Evanston, Illinois
Barnum Medical Research, Inc.
Natchitoches, Louisiana
Detroit Receiving Hospital
Detroit, Michigan
Washington University School of Medicine
St Louis, Missouri
Mercury Street Medical Group
Butte, Montana
Creighton University Medical Center
Omaha, Nebraska
New York-Presbyterian Brooklyn Methodist Hospital; Department of Emergency Medicine
Brooklyn, New York
Temple University Hospital ; Lung Center
Philadelphia, Pennsylvania
Salem Veterans Affairs Medical Center - NAVREF; Pharmacy
Salem, Virginia
Froedtert and The Medical College of Wisconsin
Milwaukee, Wisconsin
Instituto Medico Platense
La Plata, Argentina
Royal Brisbane & Womens Hospital; Pharmacy Department
Herston, Queensland, Australia
Royal Children's Hospital Melbourne - PIN
Parkville, Victoria, Australia
Hopital Erasme; Chest Medicine, Cardiac & Thoracic Surgery
Brussels, Belgium
Cliniques Universitaires Saint-Luc; Hematology
Brussels, Belgium
UZ Leuven
Leuven, Belgium
Santa Casa de Misericordia; de Belo Horizonte
Belo Horizonte, Minas Gerais, Brazil
Hospital Sao Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
Centro de Estudos Clinicos do Interior Paulista
Jaú, São Paulo, Brazil
Multiprofile Hospital For Active Treatment Sveta Ekaterina Dimitrovgrad EOOD; Internal Diseases
Dimitrovgrad, Bulgaria
Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases - Haskovo EOOD
Haskovo, Bulgaria
MHAT Stamen Iliev AD; Pharmacy
Montana, Bulgaria
University Mulitiprofile Hospital for Active Treatment Sveti Georgi EAD; Pharmacy
Plovdiv, Bulgaria
Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr. D. Gramatikov - Ruse
Rousse, Bulgaria
Multiprofile Hospital for Active Treatment - Samokov EOOD
Samokov, Bulgaria
Multiprofile Hospital For Active Treatment Sliven То Military Hospital Sofia; Pharmacy
Sliven, Bulgaria
Multiprofile Hospital For Active Treatment - Dr. Bratan Shukerov AD; Pharmacy
Smolyan, Bulgaria
First Multiprofile Hospital for Active Treatment - Sofia EAD
Sofia, Bulgaria
Fifth Multiprofile Hospital for Active Treatment - Sofia EAD; Pharmacy
Sofia, Bulgaria
Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia; Pharmacy
Sofia, Bulgaria
National Multiprofile Transport Hospital Tzar Boris Ill; Clinic of Internal Diseases
Sofia, Bulgaria
Multiprofile District Hospital for Active Treatment Dr. Stefan Cherkezov AD; Pharmacy
Veliko Tarnovo, Bulgaria
Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases-Vratsa; Pharmacy
Vratsa, Bulgaria
Institut Universitaire de Cardiologie et de Pneumologie
Québec, Canada
Peter Lougheed Centre
Calgary, Alberta, Canada
Foothills Medical Centre
Calgary, Alberta, Canada
Showing 40 of 170 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.